Ads
related to: Copd Treatments
Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 22 hours agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 8 hours agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
GuruFocus.com via Yahoo Finance· 4 hours agoThis product is poised to be the first new inhaled treatment mechanism for Chronic Obstructive Pulmonary Disease (COPD) in over two decades, pending approval ...
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoInsmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 1 day agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 8 hours agoBofA initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $80 price target. The...
Pulmonary Function Test
Health via Yahoo News· 1 day agoHealthcare providers use PFTs to: Diagnose lung conditions, such as COPD, asthma, emphysema (a form of COPD characterized by damage to the lungs' air...
Yupelri Dosage: Form, Strength, How To Use, and More
Healthline· 3 days agoYupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...
Here are Friday's biggest analyst calls of the day: Nvidia, Tesla, Apple, 3M, Bumble, Nike, Walmart,...
CNBC· 9 hours agoHere are the biggest calls on Wall Street on Friday: Bernstein reiterates Nvidia as outperform...
